Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 15
Phase 25
Phase 31

Trial Status

Completed8

Role Distribution

Principal Investigator7
Other Roles1
PI Rate88%

Activity Timeline

Clinical Trials (8)

NCT06055309Phase 1Completed
Behavioral Pharmacology of Cannabis in Older Adults
Health Services for the Aged
PrincipalinvestigatorStart date: 2025-05-01
NCT02543944Phase 2/3Completed
Improving Treatment Outcomes for Prescription Opioid Dependence
Drug Dependence
PrincipalinvestigatorStart date: 2016-02-01
NCT00593463Phase 1Completed
Drug Discrimination in Methadone-Maintained Humans Study 1
Drug Dependence
Principalinvestigator
NCT00731133Phase 1/2Completed
Open-Label Disulfiram for Methamphetamine Dependence
Methamphetamine Dependence
Principalinvestigator
NCT01557569Phase 1/2Completed
Clinical Efficacy of Atomoxetine for Methamphetamine Dependence
Methamphetamine Dependence
Principalinvestigator
NCT01895270Phase 1/2Completed
Improving Buprenorphine Detoxification Outcomes With Isradipine
Opioid Dependence
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael Mancino, MD

University of Arkansas

Related
2 trials

Shared therapeutic areas:

Drug DependenceMethamphetamine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)University of Arkansas
Collaborated on 1 trial
Similarity Score24%

Michael J Mancino, M.D.

University of Arkansas

Related
1 trials

Shared therapeutic areas:

Methamphetamine DependenceMethamphetamine Withdrawal

Worked with same sponsors:

University of Arkansas
Collaborated on 1 trial
Similarity Score24%

Colleen A Hanlon, PhD

Medical University of South Carolina

Related
9 trials

Shared therapeutic areas:

Cocaine DependenceDrug DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score13%

Rajita Sinha, PhD

Yale University

Related
11 trials

Shared therapeutic areas:

Cocaine DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score9%

Elliot Stein, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
20 trials

Shared therapeutic areas:

Cocaine DependenceDrug Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score9%

Kenzie Preston, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score9%

Mehmet Sofuoglu, M.D., Ph.D.

Yale University

Related
10 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score9%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Depressive Symptoms
Similarity Score4%

Gerhard Andersson, pHD

Linkoeping University

Related
12 trials

Shared therapeutic areas:

Depressive Symptoms
Similarity Score4%

Madhukar Trivedi, MD

University of Texas Southwestern Medical Center

Related
13 trials

Shared therapeutic areas:

Depressive Symptoms

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT06055309Phase 1PrincipalInvestigator

Behavioral Pharmacology of Cannabis in Older Adults

Health Services for the Aged
Completed
NCT02543944Phase 2/3PrincipalInvestigator

Improving Treatment Outcomes for Prescription Opioid Dependence

Drug Dependence
Completed
NCT00593463Phase 1PrincipalInvestigator

Drug Discrimination in Methadone-Maintained Humans Study 1

Drug Dependence
Completed
NCT00653263StudyChair

Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study

Methamphetamine DependenceMethamphetamine Withdrawal
Completed
NCT00654953Phase 2PrincipalInvestigator

Clinical Efficacy of Sertraline Augmented With Gabapentin in Depressed, Recently Abstinent Cocaine-dependent Humans

Cocaine DependenceDepressive Symptoms
Completed
NCT00731133Phase 1/2PrincipalInvestigator

Open-Label Disulfiram for Methamphetamine Dependence

Methamphetamine Dependence
Completed
NCT01557569Phase 1/2PrincipalInvestigator

Clinical Efficacy of Atomoxetine for Methamphetamine Dependence

Methamphetamine Dependence
Completed
NCT01895270Phase 1/2PrincipalInvestigator

Improving Buprenorphine Detoxification Outcomes With Isradipine

Opioid Dependence
Completed

All 8 trials loaded